Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE OF IMMUNOMEDICS, INC., DATED FEBRUARY 10, 2017, TITLED "IMMUNOMEDI - IMMUNOMEDICS INC | f8k021017ex99i_immunomed.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 10, 2017
Immunomedics, Inc.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 000-12104 | 61-1009366 | ||
| (State
or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 300 The American Road, Morris Plains, New Jersey | 07950 | |
| (Address of principal executive offices) | (Zip Code) |
(973)
605-8200
(Registrant’s telephone
number,
including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
On February 10, 2017, Immunomedics, Inc. (the “Company”) issued a press release announcing it has postponed the Company’s 2016 Annual Meeting of Stockholders (the “2016 Annual Meeting”) previously scheduled for February 16, 2017. As stated in the press release, the Annual Meeting has been postponed to March 3, 2017 at 10:00 a.m. Eastern Time and will be held at the Executive Offices of Immunomedics, Inc., located at 300 The American Road, Morris Plains, New Jersey 07950. The record date of January 24, 2017 has not changed.
The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
Description of Exhibit | |
| 99.1 | Press Release of Immunomedics, Inc., dated February 10, 2017, titled “Immunomedics Announces Postponement of 2016 Annual Meeting” |
| 2 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IMMUNOMEDICS, INC. | ||
| Date: February 10, 2017 | By: | /s/ Michael R. Garone |
| Name: | Michael R. Garone | |
| Title: | Vice President, Finance and Chief Financial Officer | |
3